NCT02793622View on ClinicalTrials.gov

Prevention of Malaria in HIV-uninfected Pregnant Women and Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

782

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 4, 2018

Study Completion Date

December 4, 2018

Conditions
Malaria
Interventions
DRUG

Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy

DRUG

Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy

Trial Locations (1)

Unknown

IDRC - Tororo Research Clinic, Tororo

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of California, San Francisco

OTHER

NCT02793622 - Prevention of Malaria in HIV-uninfected Pregnant Women and Infants | Biotech Hunter | Biotech Hunter